Taidoc Technology Corp

Taidoc Technology Corp maintains a conservative capital structure with a debt-to-equity ratio of 0.12, indicating limited leverage and a strong equity base. The company's liquidity position is characterized by a current ratio of 3.18, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's net cash position is negative after subtracting total debt, which raises some liquidity concerns. Profitability metrics show that Taidoc Technology Corp is performing well relative to industry standards. The company's return on equity (ROE) of 14.73% and return on assets (ROA) of 11.28% are strong indicators of efficient capital utilization and asset management. These figures suggest that the company is generating solid returns for its shareholders and effectively deploying its assets to generate income. Taidoc Technology Corp's revenue is primarily derived from the production and sale of medical equipment, with a focus on diagnostic test equipment, home care devices, and professional monitoring systems. The company's geographic exposure is concentrated in Taiwan, and it does not disclose significant international revenue streams. This concentration may expose the company to regional economic and regulatory risks. The company's growth trajectory appears stable, with a revenue of TWD 4.2 billion in the latest reporting period. While no specific growth rates are provided, the company's strong operating cash flow of TWD 853.4 million and free cash flow of TWD 425.2 million indicate a healthy cash-generating business. These cash flows support ongoing operations and potential reinvestment in the business. Risk factors for Taidoc Technology Corp include medium liquidity risk, primarily due to the negative net cash position after accounting for total debt. The company's dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's conservative capital structure and strong equity base help mitigate dilution concerns. Recent events and disclosures for Taidoc Technology Corp include analyst recommendations, with a mean recommendation of 3.00 (on a scale from 1=strong buy to 5=strong sell). There are no strong buy or buy recommendations, with one hold recommendation and no sell or strong sell recommendations. This suggests a neutral outlook from analysts, with no strong consensus for either growth or decline.